The study documented blood pressure lowering effect according to ABMP data in 50 hypertensive patients receiving antibodies to C-end fragment to AT1 receptors for 3 months. (Cardos). The drug was well-tolerated and showeed 24-hour significant decrease of blood pressure at day-time as well as at night-time.